Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.
Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.
Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.
Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Daivin is an oxygen-generating equipment manufacturing company which helps humans breathe underwater without oxygen tanks.
MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.
Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases.
FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
HealthTech Innovations is a spin-off of Hospital Germans Trias i Pujol and transforming medical care through virtual reality.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Resistell is a antibiotic resistance test.
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.
EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.
Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.
Ervaxx is illuminating the immune interface to develop new cancer therapies.
CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.
Pfizer has invested in 100 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Pfizer's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 24 different industry categories.
Among tracked funding rounds, Dren Bio received $350.0M in a Venture - Series Unknown round. Pfizer's total known invested capital is $4.7B.
Pfizer's average investment size is $93.8M across its portfolio of 100 companies.
Recent Pfizer portfolio additions include Dren Bio, Circle Pharma, TwoStep Therapeutics, Spero Therapeutics, Engine Biosciences. These companies were founded in 2020 or later.